US Patent Litigations are now available. Check here

EP2959894

NOVARTIS
Application Number
EP15177166A
Filing Date
Jun 25, 2007
Status
Granted And Under Opposition
Sep 9, 2022
Grant Date
Oct 12, 2022
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Biblio Summary

The patent EP2959894B1 was granted on Oct 12, 2022 by Novartis The patent is currently Granted And Under Opposition.

Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.

Citation PhasePatent NumberPatent LinkCited Text
OppositionEP2959894B1
N/A
OppositionWO2006058316
N/A
OppositionWO03097028
N/A
OppositionWO03099192
N/A
OppositionWO2004050073
N/A
OppositionWO2004113330
N/A
OppositionUS2006046979
N/A
OppositionWO2008000419
N/A
OppositionWO2007059188
N/A
OppositionEP2037906
N/A
OppositionEP2633864
N/A
OppositionEP2698154
N/A
OppositionGB612721
N/A
OppositionEP2959864
N/A
OppositionEP1613288
N/A

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.